Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sophia C Weinmann"'
Autor:
Lesley Ann Saketkoo, Jessica K. Gordon, Kim Fligelstone, Anne Mawdsley, Humza A. Chaudhry, Antonia Valenzuela, Angela Christensen, Samara M. Khalique, Kelly Jensen, Sophia C. Weinmann, Evan Busman, Lorinda Chung, Vivien M. Hsu, Anne-Marie Russell, Virginia D. Steen
Publikováno v:
Rheumatic Disease Clinics of North America. 49:463-481
Autor:
Anne E. Kim, Ariel Nelson, Kyle Stimpert, Rebecca L. Flyckt, Nannan Thirumavalavan, Karen C. Baker, Sophia C. Weinmann, Christopher J. Hoimes
Publikováno v:
JCO Oncology Practice. 18:815-822
Immune checkpoint inhibition has resulted in significant efficacy across many cancer types, including melanoma. Melanoma is the second most common cancer among those of reproductive age, yet the reproductive toxicities of adjuvant and first-line immu
Publikováno v:
Cancer Management and Research
The development of immune checkpoint inhibitors (ICI) has dramatically changed the clinical management of metastatic melanoma and other solid tumors. Despite exclusion from initial clinical trials, there is a growing body of retrospective data that s
Autor:
Nilasha Ghosh, Nina Couette, Wouter H. van Binsbergen, Sophia C. Weinmann, Bridget Jivanelli, Beverley Shea, Anne R. Bass, Karolina Benesova, Clifton O. Bingham, Cassandra Calabrese, Laura C. Cappelli, Karmela Kim Chan, Ernest Choy, Dimitrios Daoussis, Susan Goodman, Marie Hudson, Shahin Jamal, Jan Leipe, Maria A. Lopez-Olivo, Maria Suarez-Almazor, Conny J. van der Laken, Alexa Simon Meara, David Liew, Marie Kostine
Publikováno v:
Ghosh, N, Couette, N, van Binsbergen, W H, Weinmann, S C, Jivanelli, B, Shea, B, Bass, A R, Benesova, K, Bingham, C O, Calabrese, C, Cappelli, L C, Chan, K K, Choy, E, Daoussis, D, Goodman, S, Hudson, M, Jamal, S, Leipe, J, Lopez-Olivo, M A, Suarez-Almazor, M, van der Laken, C J, Meara, A S, Liew, D & Kostine, M 2023, ' Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica : A scoping review by the OMERACT irAE working group ', Seminars in Arthritis and Rheumatism, vol. 58, 152110 . https://doi.org/10.1016/j.semarthrit.2022.152110
Introduction: Immune checkpoint inhibitors (ICI), increasingly used cancer therapeutics, can cause off-target inflammatory effects called immune-related adverse events (irAEs), including ICI-induced inflammatory arthritis (ICI-induced IA) and polymya
Autor:
David S. Pisetsky, Sophia C Weinmann
Publikováno v:
Rheumatology (Oxford, England)
Immune checkpoint inhibitors are novel biologic agents to treat cancer by inhibiting the regulatory interactions that limit T cell cytotoxicity to tumours. Current agents target either CTLA-4 or the PD-1/PD-L1 axis. Because checkpoints may also regul
Publikováno v:
JAMA.
Publikováno v:
Common Issues in Breast Cancer Survivors ISBN: 9783030753764
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3752a67e43380aaaba74a03d5f34764f
https://doi.org/10.1007/978-3-030-75377-1_6
https://doi.org/10.1007/978-3-030-75377-1_6